Home Tags Proteomics

Tag: Proteomics

G42 Healthcare Partners with Amazon Web Services to Develop Global Genomics, Proteomics and Biobanking Service

G42 Healthcare Partners with Amazon Web Services to Develop Global Genomics, Proteomics and Biobanking...

G42 Healthcare, an Abu Dhabi-based leading health tech company and a subsidiary of artificial intelligence and cloud computing company G42, has announced a partnership with Amazon Web Services (AWS) to develop new global genomics, proteomics, and biobanking service. The collaboration...

The Pharma Proteomics Project: UK Biobank Collaborating with Biopharma Consortium to Study Plasma Proteome

UK Biobank, one of the world’s largest and most comprehensive biomedical databases and research resources, announced that a consortium of ten biopharmaceutical companies. According to UK Biobank, the Pharma Proteomics Project will be one of the world’s largest studies...

Biomarker Candidates For Dementia With Lewy Bodies Identified In Cerebrospinal Fluid

Besides Alzheimer’s disease (AD), Dementia with Lewy Bodies (DLB) is the second most common form of progressive dementia, accounting for up to 20% of cases. The main protein component of Lewy Bodies, which form in the nerve cells of...

Proteomic Study Of Alzheimer’s With ApoE4

Apolipoprotein E (APOE) is a 299 amino acid protein which can be induced by consuming foods rich in cholesterol. The APOE gene has three main alleles termed ε2-4, which are translated into the proteins ApoE2-4. Apolipoproteins play a role...

Pressure BioSciences’ PCT Platform Utilized In High-Throughput Tissue Proteomics

Pressure BioSciences, Inc. (“PBI”) is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments and related consumables for the worldwide life sciences and other industries. The Company has announced the publication two scientific journal articles,...

Olink’s Unique CVD II And CVD III Assays For Cardiac Biomarker Analysis Awarded By...

Frost & Sullivan have bestowed Olink Proteomics with the 2018 Global Enabling Technology Leadership Award for developing the company’s cardiovascular (CV) multiplex panels—CVD II and CVD III, featuring proprietary Proximity Extension Assay (PEA) technology, with minimal biobank sample consumption. Each...

⭐ Recently Featured

🔥 Popular Posts

X